SCHEMBL7856909

SCHEMBL7856909

CC(c1ccc2ccccc2c1)C(NC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB1 P18505 1/20 0.53
GABRB2 P47870 1/20 0.53
CTSK P43235 3/20 0.47
CTSS P25774 2/20 0.47
CTSB P07858 1/20 0.47
MMP9 P14780 1/20 0.44
ACE P12821 1/20 0.41
UGT2B7 P16662 1/20 0.41
PTPN1 P18031 1/20 0.41
APP P05067 1/20 0.41
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4116995 0.85 CTSK (0.51) GABRB1GABRB2CTSKCTSSACE
SCHEMBL3379781 0.85 CTSK (0.51) GABRB1GABRB2CTSKCTSSACE
SCHEMBL844407 0.85 CTSK (0.51) GABRB1GABRB2CTSKCTSSACE
SCHEMBL14250689 0.85 CTSK (0.51) GABRB1GABRB2CTSKCTSSACE
SCHEMBL3414715 0.85 CTSK (0.51) GABRB1GABRB2CTSKCTSSACE
SCHEMBL8864145 0.84 CTSK (0.51) GABRB1GABRB2CTSKCTSSCTSB
SCHEMBL11585053 0.83 GABRB1 (0.56) GABRB1GABRB2CTSKCTSSCTSB
SCHEMBL7857496 0.83 CTSK (0.48) CTSKCTSSCTSBACEAPP
SCHEMBL31230469 0.83 GABRB1 (0.56) GABRB1GABRB2CTSKCTSSCTSB
SCHEMBL9952163 0.83 GABRB1 (0.56) GABRB1GABRB2CTSKCTSSCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1119328-C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists NOVARTIS AG (CH) 2003-08-27 CN disclosed
EP-1077941-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES Novo Nordisk A/S (DK) 2001-02-28 EP disclosed
WO-1999058501-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1999-11-18 WO disclosed
CN-1233238-A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists NOVARTIS AG (CH) 1999-10-27 CN disclosed